CRMD CORMEDIX INC US FDA Inspections 8-K Filing 2023 - Other Events CorMedix Inc. announced that the New Drug Application for DefenCath has been approved by the U.S. Food and Drug Administration.Get access to all SEC 8-K filings of the CORMEDIX INC